B

Bicara Therapeutics Inc.
D

BCAX

9.17000
USD
-0.14
(-1.50%)
مغلق
حجم التداول
12,984
الربح لكل سهم
-2
العائد الربحي
-
P/E
-5
حجم السوق
500,097,119
المقالات

العنوان: Bicara Therapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.